Fasudil

This classification denotes a protein kinase inhibitor with the molecular formula C14H17N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q0CH43PGXS, chemically known as 5-(1,4-diazepan-1-sulfonyl)isoquinoline but generally known as fasudil, which bears US NIH Compound Identifier 3547. European Medicines Agency schedules Fasudil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07515MIG. The term FASUDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules fasudil in its Anatomical Therapeutic Chemical (ATC) Classification. FASUDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fasudil under HS 29350090 and SITC 51580. As of Q4 2014, FASUDIL remains the US FDA Preferred Term for this commodity. Fasudil bears US NLM identifiers UMLS ID C0062068 and NCI Concept Code C65624. SMILES: S(=O)(=O)(N1CCCNCC1)c1c2c(ccc1)cncc2.